Medroxyprogesterone Acetate Suspension Recalled for Sterility Concerns
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling Medroxyprogesterone Acetate 150 mg/mL suspension because the manufacturer cannot assure the product's sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterile injectable product where sterility assurance cannot be provided. Loss of sterility in injectable medications poses a serious risk of infection and could require hospitalization, meeting the Class II with risk-of-serious-injury criterion.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling 696 vials of Medroxyprogesterone Acetate 150 mg/mL suspension (Rx only) distributed across the United States, including Washington, D.C. and Puerto Rico.
The recall was initiated because the manufacturer lacks assurance of the product's sterility. The affected lots are: 07222021:40 (BUD 10/20/2021), 03302021:60 (BUD 10/26/2021), 04122021:29 (BUD 11/08/2021), 08172021:38 (BUD 11/15/2021), and 07072021:60 (BUD 10/05/2021).
Healthcare providers and patients who have received or are holding this product should contact their pharmacy or healthcare provider. Patients should not use the recalled product without consulting their healthcare provider.
The recalled product
- Product
- MEDROXYPROGESTERONE ACET 150MG/ML SUSP (PF) 150MG/ML SUSPENSION, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- lack-of-sterility
- contamination-risk
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot: 07222021:40 BUD: 10/20/2021
- 03302021:60 BUD: 10/26/2021
- 04122021:29 BUD: 11/08/2021
- 08172021:38 BUD: 11/15/2021
- 07072021:60 BUD: 10/05/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27